Current Appointments & Affiliations
Assistant Professor of Radiation Oncology
·
2024 - Present
Radiation Oncology,
Clinical Science Departments
Member of the Duke Cancer Institute
·
2022 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Assessment of minimum target dose as a predictor of local failure after spine SBRT.
Conference Radiother Oncol · June 2024 OBJECTIVES: Metastasis-directed stereotactic body radiation therapy (SBRT) has demonstrated robust clinical benefits in carefully selected patients, improving local control and even overall survival (OS). We assess a large database to determine clinical an ... Full text Link to item CiteDeterminants of Symptomatic Intracranial Progression After an Initial Stereotactic Radiosurgery Course.
Journal Article Adv Radiat Oncol · June 2024 PURPOSE: Clinical and imaging surveillance of patients with brain metastases is important after stereotactic radiosurgery (SRS) because many will experience intracranial progression (ITCP) requiring multidisciplinary management. The prognostic significance ... Full text Link to item CiteNon-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal Article J Natl Compr Canc Netw · May 2024 The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) provide recommendations for the treatment of patients with NSCLC, including diagnosis, primary disease management, surveillance for relapse, and subs ... Full text Link to item CiteRecent Grants
Phase 2 Randomized Clinical Trial Comparing the Safety and Efficacy of PULSAR-Integrated Radiotherapy + Pembrolizumab or Nivolumab Administered with or without STING-Agonist IMSA101 in Patients with Oligometastatic Non-Small Cell Lung Cancer and Rena
Clinical TrialPrincipal Investigator · Awarded by ImmuneSensor Therapeutics, Inc. · 2024 - 2024View All Grants
Education, Training & Certifications
Mayo Clinic, Alix School of Medicine ·
2016
M.D.